Global Corneal Transplant Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Corneal Transplant market size will reach US$ 2267 million by 2031.
Corneal Transplant (keratoplasty) is a common transplantation procedure with a very high success rate. A scarred, severely painful, perforated, deformed or cloudy cornea (the clear layer in front of the iris and pupil) can be replaced with a clear, healthy cornea.
The donated cornea comes from a recently deceased person. Tissue matching is not routinely required because rejection is relatively rare and can usually be treated (see Complications of corneal transplantation). Transplantation is most likely to be successful when it is performed for diseases such as bullous keratopathy, keratoconus and certain corneal scars.
In a broad sense, corneal transplantation refers to replacing cloudy and diseased corneal tissue with foreign materials to achieve the purpose of restoring the patient's vision or controlling corneal diseases and beauty. Therefore, it includes allogeneic corneal transplantation, xenogeneic corneal transplantation, autologous corneal transplantation, tissue-engineered corneal transplantation and artificial corneal transplantation. Corneal transplantation usually refers to allogeneic corneal transplantation, which is to use normal corneal tissue of a foreign body to replace cloudy or diseased corneal tissue to restore vision or control corneal lesions. It is the one with the highest success rate among allogeneic organ transplants and one of the important eye restoration surgeries. The scope of this report is the various expenses incurred during corneal transplantation, including surgical expenses, consumables, cornea, anesthetic drugs, and various disposal costs during the treatment process.
Aging populations in developed and emerging economies lead to higher rates of corneal degeneration and diseases.
Age-related corneal endothelial failure (Fuchs’ dystrophy) is one of the common indications for endothelial keratoplasty.
Advancements in Surgical Techniques
Minimally invasive techniques like DALK, DSEK, and DMEK offer faster recovery, better visual outcomes, and lower rejection rates compared to traditional PK.
The adoption of femtosecond lasers for precise cuts and better graft alignment has improved surgical success rates.
Expansion of Eye Banks and Donor Programs
Improved awareness campaigns and government initiatives have increased corneal tissue donations in many countries.
Technological progress in cornea preservation (e.g., hypothermic storage, organ culture) extends tissue shelf-life and facilitates international tissue exchange.
Increasing Healthcare Expenditure & Insurance Coverage
Rising disposable income, better access to healthcare services, and broader insurance coverage in developing economies boost the affordability of advanced eye surgeries.
Non-profit organizations and international collaborations provide support for surgeries in low-resource settings.
Innovation in Artificial Corneas (Keratoprostheses)
For patients unsuitable for traditional donor grafts or repeat graft failure, keratoprostheses (e.g., Boston KPro) offer hope.
Advances in biocompatible materials and design improve long-term outcomes for severe cases.
LPI (LP Information)' newest research report, the “Corneal Transplant Industry Forecast” looks at past sales and reviews total world Corneal Transplant sales in 2024, providing a comprehensive analysis by region and market sector of projected Corneal Transplant sales for 2025 through 2031. With Corneal Transplant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Corneal Transplant industry.
This Insight Report provides a comprehensive analysis of the global Corneal Transplant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Corneal Transplant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Corneal Transplant market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Corneal Transplant and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Corneal Transplant.
This report presents a comprehensive overview, market shares, and growth opportunities of Corneal Transplant market by product type, application, key players and key regions and countries.
Segmentation by Type:
Penetrating Keratoplasty
Endothelial Keratoplasty
Descemet Stripping Automated Endothelial Keratoplasty
Corneal Limbal Stem Cell Transplant
Others
Segmentation by Application:
Hospital
Eye Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CryoLife, Inc.
Exactech, Inc.
Köhler GmbH
Lifeline Scientific
LIFECELL CORPORATION
Medtronic
Please note: The report will take approximately 2 business days to prepare and deliver.
Corneal Transplant (keratoplasty) is a common transplantation procedure with a very high success rate. A scarred, severely painful, perforated, deformed or cloudy cornea (the clear layer in front of the iris and pupil) can be replaced with a clear, healthy cornea.
The donated cornea comes from a recently deceased person. Tissue matching is not routinely required because rejection is relatively rare and can usually be treated (see Complications of corneal transplantation). Transplantation is most likely to be successful when it is performed for diseases such as bullous keratopathy, keratoconus and certain corneal scars.
In a broad sense, corneal transplantation refers to replacing cloudy and diseased corneal tissue with foreign materials to achieve the purpose of restoring the patient's vision or controlling corneal diseases and beauty. Therefore, it includes allogeneic corneal transplantation, xenogeneic corneal transplantation, autologous corneal transplantation, tissue-engineered corneal transplantation and artificial corneal transplantation. Corneal transplantation usually refers to allogeneic corneal transplantation, which is to use normal corneal tissue of a foreign body to replace cloudy or diseased corneal tissue to restore vision or control corneal lesions. It is the one with the highest success rate among allogeneic organ transplants and one of the important eye restoration surgeries. The scope of this report is the various expenses incurred during corneal transplantation, including surgical expenses, consumables, cornea, anesthetic drugs, and various disposal costs during the treatment process.
Aging populations in developed and emerging economies lead to higher rates of corneal degeneration and diseases.
Age-related corneal endothelial failure (Fuchs’ dystrophy) is one of the common indications for endothelial keratoplasty.
Advancements in Surgical Techniques
Minimally invasive techniques like DALK, DSEK, and DMEK offer faster recovery, better visual outcomes, and lower rejection rates compared to traditional PK.
The adoption of femtosecond lasers for precise cuts and better graft alignment has improved surgical success rates.
Expansion of Eye Banks and Donor Programs
Improved awareness campaigns and government initiatives have increased corneal tissue donations in many countries.
Technological progress in cornea preservation (e.g., hypothermic storage, organ culture) extends tissue shelf-life and facilitates international tissue exchange.
Increasing Healthcare Expenditure & Insurance Coverage
Rising disposable income, better access to healthcare services, and broader insurance coverage in developing economies boost the affordability of advanced eye surgeries.
Non-profit organizations and international collaborations provide support for surgeries in low-resource settings.
Innovation in Artificial Corneas (Keratoprostheses)
For patients unsuitable for traditional donor grafts or repeat graft failure, keratoprostheses (e.g., Boston KPro) offer hope.
Advances in biocompatible materials and design improve long-term outcomes for severe cases.
LPI (LP Information)' newest research report, the “Corneal Transplant Industry Forecast” looks at past sales and reviews total world Corneal Transplant sales in 2024, providing a comprehensive analysis by region and market sector of projected Corneal Transplant sales for 2025 through 2031. With Corneal Transplant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Corneal Transplant industry.
This Insight Report provides a comprehensive analysis of the global Corneal Transplant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Corneal Transplant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Corneal Transplant market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Corneal Transplant and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Corneal Transplant.
This report presents a comprehensive overview, market shares, and growth opportunities of Corneal Transplant market by product type, application, key players and key regions and countries.
Segmentation by Type:
Penetrating Keratoplasty
Endothelial Keratoplasty
Descemet Stripping Automated Endothelial Keratoplasty
Corneal Limbal Stem Cell Transplant
Others
Segmentation by Application:
Hospital
Eye Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CryoLife, Inc.
Exactech, Inc.
Köhler GmbH
Lifeline Scientific
LIFECELL CORPORATION
Medtronic
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
83 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Corneal Transplant Market Size by Player
- 4 Corneal Transplant by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Corneal Transplant Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
